Tag: Bharat Biotech
India approves its first nasal vaccine for COVID-19
India approved a locally developed, needle-free and nasally administered Covid-19 vaccine for…
Covaxin safe, well tolerated in 2-18 years age group: Bharat Biotech
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has…
Biological E. Covid shot Corbevax gets India emergency approval for 12-18 age group
Indian vaccine maker Biological E. Ltd said on Monday its Covid-19 vaccine…
Serum Institute resumes exports of Covishield vaccine
Serum Institute of India on Friday said it has resumed exports of…
6 months after 2nd Covid shot best time for booster: Bharat Biotech chief Krishna Ella
Bharat Biotech chief and the developer of India’s first indigenously made Covid…
India’s Bharat Biotech says vaccine 93.4% effective on severe COVID
Phase III trials of a vaccine made by India's Bharat Biotech showed…
‘Covaxin pricing clearly established’: Bharat Biotech clarifies on Brazil deal row
Bharat Biotech on Wednesday issued a clarification over the procurement process of…
Covaxin’s phase 3 results soons, says Bharat Biotech
Bharat Biotech on Saturday said scientific standards and commitment of the indigenously-developed…
India to provide free Covid shots to adults in major policy shift
India will provide free Covid-19 vaccines to all adults, Prime Minister Narendra…
Covaxin may get WHO nod soon: Bharat Biotech
Though no country has instituted a vaccine passport as yet, Foreign Secretary…
Bharat Biotech’s Karnataka facility to manufacture 5 crore Covaxin doses by August-end
Bharat Biotech's Covaxin manufacturing facility that is under construction in Kolar district…
Reduce vaccine price: Govt tells Serum Institute, Bharat Biotech
The Centre has asked Serum Institute of India and Bharat Biotech, manufacturers…
COVAXIN priced at Rs 600 a dose for states; Rs 1,200 a dose for private hospitals
Bharat Biotech, the maker of indigenous COVID shot COVAXIN on Saturday said…
Hackers target ‘Indian vaccine makers SII, Bharat Biotech’
A Chinese state-backed hacking group has in recent weeks targeted the IT…
Covaxin can be modified to neutralise South African variant in 15 days: Bharat Biotech
Makers of Covaxin, Bharat Biotech has said that they can modify the…
Indian state rejects Bharat Biotech vaccine approved without efficacy data
Chhattisgarh, an opposition-ruled Indian state, has said it had asked the government…
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
Global healthcare company GSK, non-profit agency working to end health inequity PATH,…
8.1 lakh Covaxin doses to be procured from Bharat Biotech for other countries
The Union Health Ministry on Saturday asked the Ministry of External Affairs…
Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in February-March
Buoyed by the Emergency Use Authorisation approval from the Drug Controller General…
Bharat Biotech gets permission to manufacture ‘Covaxin’ for sale
The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech…
Indian vaccine Covaxin has drawn global attention: ICMR
The Indian Council of Medical Research (ICMR) has said that the Indian…
COVID-19: Bharat Biotech confirms adverse event during vaccine trial
Hyderabad-based vaccine maker Bharat Biotech has rejected reports that it did not…
India’s first Covid-19 vaccine will be at least 60% effective: Bharat Biotech
India’s first coronavirus disease (Covid-19) vaccine candidate Covaxin, which is being developed…